Concepedia

Publication | Closed Access

Response to Lenvatinib in Children with Papillary Thyroid Carcinoma

31

Citations

19

References

2018

Year

Abstract

Lenvatinib therapy is well tolerated and demonstrated clinical activity in children with advanced PTC. Lenvatinib should be considered in children with PTC that is refractory or not amenable to conventional management.

References

YearCitations

Page 1